NASDAQ:MACK

Merrimack Pharmaceuticals, Inc.

Stock

USD

Last Close

15.13

17/05 19:59

Market Cap

223.97M

Beta: 1.80

Volume Today

922.50K

Avg: 70.31K

PE Ratio

−152.04

PFCF: −135.35

Overview Financials API

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Excel Tearsheet

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '14	Dec '15	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
revenue	102.76M -	89.26M 13.14%	144.27M 61.64%						-445K -
cost of revenue		46K -	6.91M 14,926.09%
gross profit	102.76M -	89.21M 13.18%	137.36M 53.97%						-445K -
selling and marketing expenses
general and administrative expenses	30.52M -			28.45M -	15.60M 45.17%	16.17M 3.64%	5.01M 69.00%	2.62M 47.81%	2.17M 16.90%	2.18M 0.09%
selling general and administrative expenses	30.52M -	57.59M 88.73%	80.73M 40.17%	28.45M 64.76%	15.60M 45.17%	16.17M 3.64%	5.01M 69.00%	2.62M 47.81%	2.17M 16.90%	2.18M 0.09%
research and development expenses	138.50M -	160.99M 16.24%	160.92M 0.04%	67.31M 58.17%	49.97M 25.76%	11.10M 77.79%
other expenses	-17.30M -	-18.22M 5.28%	-43.38M 138.13%	-1.43M 96.70%	-3.23M 125.40%	370K 111.46%	-191K 151.62%
cost and expenses	169.01M -	218.63M 29.36%	248.56M 13.69%	95.77M 61.47%	65.58M 31.53%	27.27M 58.42%	5.01M 81.62%	2.62M 47.81%	2.17M 16.90%	2.18M 0.09%
operating expenses	169.01M -	218.58M 29.33%	241.65M 10.55%	95.77M 60.37%	65.58M 31.53%	27.27M 58.42%	5.01M 81.62%	2.62M 47.81%	2.17M 16.90%	2.18M 0.09%
interest expense	18.23M -	19.23M 5.50%	43.65M 126.94%	34.65M 20.61%	956K 97.24%	1.53M 59.83%			-188K -
ebitda	-66.26M -	-129.37M 95.26%	-98.43M 23.92%	-91.08M 7.46%	-63.43M 30.36%	-23.89M 62.33%	-5.15M 78.43%	-2.76M 46.44%	-2.62M 5.11%	-2.18M 16.91%
operating income	-66.26M -	-129.57M 95.56%	-110.14M 15.00%	-95.77M 13.05%	-65.58M 31.53%	-22.36M 65.90%	-2.87M 87.15%	-2.47M 13.96%	-1.73M 30.06%	-2.18M 25.85%
depreciation and amortization	3.22M -	4.29M 33.04%	6.25M 45.73%	5.22M 16.45%	4.07M 21.97%	-1.53M 137.68%	-2.28M 48.53%	-288K 87.37%	-890K 209.03%
total other income expenses net	-17.30M -	-18.22M 5.28%	-49.23M 170.27%	11.12M 122.58%	-3.23M 129.05%	-381K 88.20%	-141K 62.99%	20K 114.18%	188K 840%	1.01M 435.64%
income before tax	-83.56M -	-147.79M 76.87%	-153.52M 3.88%	-118.40M 22.87%	-68.46M 42.18%	-22.74M 66.78%	-3.01M 86.75%	-2.45M 18.65%	-1.54M 37.15%	-1.17M 24.14%
income tax expense	-3.49M -	-3.92M 12.23%	-13.22M 237.52%	-42.40M 220.62%	-7.70M 81.85%	-1.47M 80.86%	14K 100.95%	3K 78.57%	3K 0%	12K 300%
net income	-83.29M -	-147.96M 77.64%	-151.74M 2.56%	472.03M 411.08%	-40.51M 108.58%	-21.27M 47.50%	-3.03M 85.76%	-2.46M 18.92%	-1.54M 37.11%	-1.18M 23.51%
weighted average shs out	10.44M -	11.14M 6.65%	12.53M 12.55%	13.23M 5.58%	13.34M 0.84%	13.35M 0.07%	13.38M 0.20%	13.41M 0.20%	13.52M 0.87%	14.30M 5.73%
weighted average shs out dil	10.44M -	11.14M 6.65%	12.53M 12.55%	13.23M 5.58%	13.34M 0.84%	13.35M 0.07%	13.38M 0.20%	13.41M 0.20%	13.52M 0.87%	14.30M 5.73%
eps	-7.98 -	-13.29 66.54%	-12.11 8.88%	35.67 394.55%	-3.04 108.52%	-1.59 47.70%	-0.23 85.53%	-0.18 21.74%	-0.11 38.89%	-0.08 24.91%
epsdiluted	-7.98 -	-13.29 66.54%	-12.11 8.88%	35.67 394.55%	-3.04 108.52%	-1.59 47.70%	-0.23 85.53%	-0.18 21.74%	-0.11 38.89%	-0.08 24.91%

All numbers in USD (except ratios and percentages)